|
The 2026 CVP Provider Agreement Renewal period ends April 30, 2026. If you haven't completed your renewal yet, now is the time. Some 2025 agreements expired March 31 and all remaining agreements will expire April 30. Providers without an approved agreement will not be able to place orders.
After submitting, be sure to check that the agreement is approved and has not been returned for edits. If your agreement has been returned, check the comments displayed at the top of the returned agreement. These notes explain what needs to be corrected before resubmitting.
Provider Agreement Renewal Resources
Once your 2026 agreement is approved, please do not create a new agreement in the IIS unless you need to update the signatory, shipping address, or facility name. To request changes, email WAChildhoodVaccines@doh.wa.gov.
Beginning this week, the Childhood and Adult Vaccine Programs will transition to processing the NEW Vaccine Loss Survey (VLS) in REDCap to improve efficiency.
The VLS will replace the paper format of the Vaccine Loss Log, which is currently submitted via email. Moving forward, if you report a monthly vaccine loss of $2500 or more in the WAIIS, you’ll receive a REDCap survey link from us by email.
Please review the important dates below outlining steps in the transition to the new process:
- The first Vaccine Loss Surveys will be sent to providers with $2500+ in monthly vaccine loss on Wednesday, April 22.
- The April CVP Training Series: Process Update, NEW Vaccine Loss Survey will follow on Thursday, April 23 at noon, to support providers with this transition.
- After the initial launch, providers with $2500+ in monthly vaccine loss will get Vaccine Loss Surveys on the first Wednesday of each month, beginning on May 6.
Important: Continue to post the Vaccine Loss Log near your storage units to track monthly waste, and retain these forms for three years. Submitting the log by email is no longer required.
The Washington State Department of Health (DOH) has launched a new Vaccine Recommendations webpage in response to House Bill 2242 (PDF). The page provides current state immunization recommendations and related guidance for health care providers and local health jurisdictions.
It includes PDF schedules for childhood and adolescent and adult immunizations, along with answers to frequently asked questions. Recommendations are based on evidence from leading medical and public health organizations and outline who should receive vaccines, when, and under what conditions.
Providers and partners can access the new webpage to review current guidance and stay up to date on recommendations.
All vaccines recommended by DOH remain available at no cost for children under age 19 through Washington’s Childhood Vaccine Program (CVP) at participating providers. Uninsured adults ages 19 and older can receive recommended vaccines at no cost through the Adult Vaccine Program (AVP).
For additional information, visit the Immunizations and Vaccines page. For questions about Washington’s immunization recommendations, contact OI@doh.wa.gov.
Visit the new Vaccine Recommendations webpage to learn more.
Get ready to celebrate the incredible work your clinic is doing to protect children across Washington. Nominations for the Immunize WA Awards – open to clinics enrolled in the Childhood Site Visit Program - will run June 1 through July 15, 2026, with awardees announced during the third week of August.
Take action now: Review your coverage rate reports by following the instructions on the Immunize WA web page to make sure your clinic is ready before nominations open.
Don’t miss your chance to be recognized for your team’s dedication and impact!
Have questions or need support? Reach out anytime at immunizewa@doh.wa.gov – we’re here to help.
The Washington State Department of Health (DOH) extended the RSV monoclonal antibody administration period for infants through April 30, 2026, due to a delayed and prolonged RSV season with continued elevated activity statewide. Providers should end the administration of RSV monoclonal antibodies (nirsevimab or clesrovimab) on April 30. For questions about RSV immunization product ordering or dose transfers, contact us at WAChildhoodVaccines@doh.wa.gov.
An infant born at the end of the RSV season and who received one dose of nirsevimab or clesrovimab and are still younger than 8 months of age their second RSV season, but don’t meet the high-risk criteria, will not need to get a monoclonal antibody in the fall. Also, children younger than 8 months of age born near the end of the previous RSV season to mothers who received Abrysvo RSV vaccine during pregnancy are NOT recommended to receive an RSV preventive antibody product at the beginning of the next season.
Resources
A provider alert was sent last week regarding an increased risk for measles in Washington state. A rise in travel-related cases and local transmission (with possible unidentified community transmission) is increasing the risk for measles across WA. Providers should do the following:
-
Identify: Be prepared to recognize and appropriately manage cases of measles.
-
Notify: IMMEDIATELY report all suspected cases of measles to your Local Health Jurisdiction.
-
Test & Manage: Understand how to test for measles and how to manage cases in your facility.
-
Assess & Vaccinate: Ensure all pediatric and adult patients without evidence of immunity are up to date on measles vaccination.
For more information, please review the entire Provider Alert regarding increased risk for measles in Washington state.
For additional questions, or to report suspect cases, please contact the Vaccine-Preventable Disease (VPD) Program at vpd-cde@doh.wa.gov or 206-418-5500.
Did you know that the IIS has a Reminder/Recall tool that be can be used to identify patients that are due or overdue for vaccinations? Using the Reminder/Recall helps keep your patients up-to-date with recommended vaccines and can help utilize soon-to-expire vaccines in your inventory.
|
